TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
Pharmaq Fishteq AS
Closing information (x1000 NOK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
53,939
|
48,879
|
49,277 |
Financial expenses |
1,715
|
1,296
|
1,497 |
Earnings before taxes |
8,738
|
-27,048
|
-3,491 |
Total assets |
36,790
|
68,312
|
71,510 |
Current assets |
22,288
|
50,745
|
29,123 |
Current liabilities |
18,415
|
56,412
|
58,117 |
Equity capital |
18,373
|
11,623
|
12,807 |
- share capital |
85
![]() |
85
![]() |
85 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
49.9%
|
17.0%
|
17.9% |
Turnover per employee | |||
Profit as a percentage of turnover |
16.2%
|
-55.3%
|
-7.1% |
Return on assets (ROA) |
28.4%
|
-37.7%
|
-2.8% |
Current ratio |
121.0%
|
90.0%
|
50.1% |
Return on equity (ROE) |
47.6%
|
-232.7%
|
-27.3% |
Change turnover |
5,060
|
-398
|
5,390 |
Change turnover % |
10%
|
-1%
|
12% |
Chg. No. of employees | |||
Chg. No. of employees % |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.